Howard Hughes Medical Institute’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-423
Closed -$103K 140
2017
Q2
$103K Buy
+423
New +$99.4K 0.02% 137
2016
Q4
Sell
-2,878
Closed -$663K 175
2016
Q3
$663K Sell
2,878
-7,228
-72% -$1.77M 0.17% 83
2016
Q2
$2.33M Sell
10,106
-977
-9% -$225K 0.78% 45
2016
Q1
$2.97M Buy
11,083
+1,636
+17% +$468K 0.65% 38
2015
Q4
$2.95M Sell
9,447
-1,318
-12% -$392K 0.45% 37
2015
Q3
$2.93M Buy
10,765
+1,799
+20% +$553K 0.55% 35
2015
Q2
$2.72M Buy
8,966
+91
+1% +$27.1K 0.58% 44
2015
Q1
$2.64M Buy
8,875
+6,297
+244% +$1.8M 0.36% 47
2014
Q4
$664K Buy
2,578
+1,661
+181% +$415K 0.18% 74
2014
Q3
$221K Buy
917
+515
+128% +$115K 0.05% 117
2014
Q2
$90K Buy
+402
New +$83.2K 0.02% 128

Other funds holding AGN

Howard Hughes Medical Institute's AGN Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 423 shares — an estimated $103K sold.

Howard Hughes Medical Institute first reported a position in AGN in Q2 2014 and held it in 11 quarters. The position peaked at $2.97M in Q1 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 423 Allergan plc shares in Q3 2017, an estimated $103K.
  • Howard Hughes Medical Institute first reported a position in Allergan plc in Q2 2014 and held it in 11 quarters.
  • Howard Hughes Medical Institute's Allergan plc position peaked at $2.97M in Q1 2016.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.